by rss feed | Sep 1, 2024 | Felicia Pagliuca, Liveyon, News Feeds, stem cells for diabetes, Vertex, weekly reads
How is research looking on stem cells for diabetes? I’m feeling more encouraged about the clinical research in that area. Before we jump into that let’s talk about two other things. The big news of the week was the felony plea deal by Liveyon’s John...
by rss feed | Mar 3, 2024 | Diabetes, News Feeds, Vertex, weekly reads
Vertex Pharmaceuticals has a lot going for it right now on the cell therapy front. For instance, they have the strongest type 1 diabetes cell therapy pipeline after some recent acquisitions. Still it’s not a simple matter to succeed in the cell therapy space...
by rss feed | Mar 3, 2024 | Diabetes, News Feeds, Vertex, weekly reads
Vertex Pharmaceuticals has a lot going for it right now on the cell therapy front. For instance, they have the strongest type 1 diabetes cell therapy pipeline after some recent acquisitions. Still it’s not a simple matter to succeed in the cell therapy space...
by rss feed | Jan 14, 2024 | CRISPR Therapeutics, Deaths & Tributes, News Feeds, Vertex, weekly reads
The biotechs Vertex and CRISPR Therapeutics have an interesting relationship as biotechs. They are partners are multiple levels but also are very different as companies including in size. There’s been a key development in one of their partnerships. Before we...
by rss feed | Jul 26, 2022 | biotechs, News, News Feeds, Semma, stem cells for diabetes, Vertex, ViaCyte, VX-880
When I’m asked about the most promising areas of stem cell clinical research, cell therapy for type I diabetes is near the top including work by a biotech called ViaCyte. Other firms are in the mix too, boosting the overall odds of success in the coming decade....
by rss feed | Jan 4, 2022 | Diabetes, News Feeds, Predictions, Vertex, ViaCyte
The last few years in the stem cell and regenerative medicine arena have been complicated in many ways. Variables like surging stem cell clinics and COVID have made predictions harder. Even so, trying to make predictions is useful and it’s fun to go over past...
